US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for previously untreated metastatic bladder cancer

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement